Quironsalud Madrid
Metastases in the liver treatment cost in Spain runs from $35,000 to $55,000 for a liver resection, while a PET-CT scan typically costs $200 to $500. Total expenses depend on the intervention type, tumor stage, and clinic tier. Patients often save approximately 30-50% compared to the US. Top treatment destinations include Barcelona, Madrid, and Pamplona.
Typical Metastases In The Liver Treatment Costs in Spain
Bookimed Expert Insight: Patients requiring complex surgical intervention should prioritize JCI-accredited centers in Barcelona or Madrid. Centro Médico Teknon is a top choice for celebrities, providing high-volume surgical expertise. For those seeking advanced research-driven care, Hospital Universitario HM Sanchinarro offers pioneering liquid biopsy programs. Clinica Universidad de Navarra is best for multi-disciplinary excellence, boasting high survival rates for complex oncological cases.
| Turkey | Austria | Spain | |
| Removal of liver cancer | from $10,800 | from $40,000 | from $35,000 |
| Radiofrequency ablation of the liver | from $3,500 | from $12,000 | from $8,500 |
| Liver resection | from $11,700 | from $35,000 | from $35,000 |
| Chemoembolization of the liver | from $7,500 | from $16,000 | from $12,000 |
| Chemotherapy for liver cancer | from $1,800 | - | from $581 |
Dr. Jaume Capdevila has performed over 1,100 treatments for oncology patients, specializing in advanced cancer cases at Centro Médico Teknon.
Dr. Lana Bijelic is an oncological surgeon specializing in peritoneal carcinomatosis, trained under Prof. Paul Sugarbaker at Washington Hospital Center.
Dr. Cubillo Gracián combines clinical expertise with academic leadership, teaching oncology at USP CEU and directing postgraduate research at HM CIOCC.
The doctor is a pediatric oncologist with 37 years of experience, specializing in the treatment of blood disorders and performing procedures like bone marrow transplants and ablation therapy. The doctor is currently the Head of Paediatric Haemato-Oncology at Quironsalud Madrid University Hospital.
With a prolific academic record, the doctor has edited 14 books, contributed to 75 book chapters, and presented at over 200 conferences. The doctor is a member of several professional associations, including the Spanish Association of Paediatric Haematology and the Spanish Association of Paediatric Oncology.
The doctor treats a wide range of conditions, including leukemia, lymphoma, multiple myeloma, and various hematological and autoimmune disorders.
Spanish centers offer advanced surgical techniques for unresectable liver metastases including ALPPS, two-stage hepatectomies, and histotripsy. These protocols focus on rapid liver regeneration and non-thermal tumor destruction. Specialist teams in Madrid and Barcelona utilize intraoperative navigation to preserve healthy parenchymal tissue during resection.
Bookimed Expert Insight: Spain is a global leader in high-volume hepatobiliary care, with centers like Centro Médico Teknon performing 23,500 operations annually. Data shows that Spanish specialists like Dr. Lana Bijelic often combine resection with intraoperative ablation. This allows treatment of multiple nodules that would typically be deemed unresectable elsewhere. Choosing centers with multidisciplinary liver boards ensures access to these combined-modality protocols.
Patient Consensus: Patients often find that seeking a second opinion at high-volume Spanish centers is vital. They note that what one hospital labels unresectable may be eligible for staged surgery or ablation-assisted resection.
Spanish medical centers offer non-surgical local therapies including percutaneous ablation, transarterial procedures, and targeted radiation. These treatments destroy liver tumors without major surgery. Options like radiofrequency ablation (RFA) and chemoembolization are available at JCI-accredited facilities in Madrid and Barcelona.
Bookimed Expert Insight: Spanish oncology centers like Centro Médico Teknon and Hospital Ruber Internacional stand out due to their high patient volumes and JCI accreditation. Data shows these facilities manage over 10,000 cases annually. This volume correlates with deep expertise in managing complex oligometastatic liver disease through multidisciplinary tumor boards.
Patient Consensus: Patients note it's important to confirm if a center has on-site interventional radiology. Many emphasize requesting a multidisciplinary review to choose between ablation and SIRT.
Patients can access pioneering clinical trials for liver metastases in Spain. The country is a leading European oncology research hub. Specialized trials focus on molecular profiling and liver-directed therapies. Leading centers like Quironsalud Madrid and Hospital Universitario HM Sanchinarro authorize numerous clinical studies yearly.
Bookimed Expert Insight: Spain’s clinical trial landscape allows for unique opportunities where treatment costs might be fully covered for eligible participants. At Quironsalud Madrid, our data shows patients can potentially access therapy for free if they meet strict study criteria. This is particularly valuable for liver metastases where traditional treatment costs can rise quickly.
Patient Consensus: Patients note that having a doctor who understands the trial network is vital for successful entry. They emphasize that specific tumor markers often determine if you qualify for the most advanced research pathways.
Spain hosts several JCI-accredited facilities specializing in liver metastasis, including Centro Médico Teknon in Barcelona and Clinica Universidad de Navarra in Pamplona. These centers utilize multidisciplinary teams to provide liver resection, radiofrequency ablation, and chemoembolization. Leading specialists like Dr. Jaume Capdevila coordinate complex oncology care.
Bookimed Expert Insight: Patient volume indicates that high-capacity centers like Hospital HM Nou Delfos treat 400,000 patients annually. This massive scale often correlates with faster diagnostic turnaround for complex cases. Large multi-center groups like HM Hospitales ensure specialized oncology teams are available across their 7 integrated facilities.
Patient Consensus: Patients emphasize that multidisciplinary reviews are vital. It is common to travel to Madrid or Barcelona for evaluation at high-volume liver units.
Spanish oncologists stage liver metastases by combining high-resolution triple-phase CT or contrast-enhanced MRI with mandatory genomic profiling. They categorize cases into resectable, borderline, or unresectable phenotypes. Treatment plans are designed by multidisciplinary tumor boards to ensure personalized, multimodal care for every patient.
Bookimed Expert Insight: Spanish centers like Clinica Universidad de Navarra and Centro Médico Teknon provide a distinct advantage through high patient volumes. Clinica Universidad de Navarra treats over 140,000 patients from 70 countries annually. This vast experience allows their multidisciplinary boards to manage complex cases that smaller centers might deem untreatable.
Patient Consensus: Patients note that staging involves the entire disease picture rather than just liver scans. They emphasize that initial unresectability can change, as chemotherapy often shrinks tumors enough to allow for later surgery.